Newborn screening methods for cystic fibrosis

di Sant’Agnese, 1956, Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas, Pediatrics, 12, 549, 10.1542/peds.12.5.549 Gibson, 1959, A test for the concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoresis, Pediatrics, 23, 545, 10.1542/peds.23.3.545 Stephan, 1975, Cystic fibrosis detection by means of a test strip, Pediatrics, 55, 35, 10.1542/peds.55.1.35 Crossley, 1979, Dried blood spot screening for cystic fibrosis in the newborn, Lancet, i, 472, 10.1016/S0140-6736(79)90825-0 Wilcken, 1993, Newborn screening for cystic fibrosis: its evolution and a review of the current situation, Screening, 2, 43, 10.1016/0925-6164(93)90017-D Farrell, 2001, Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth, Pediatrics, 107, 1, 10.1542/peds.107.1.1 Chatfield, 1991, Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening, Arch Dis. Child, 66, 29, 10.1136/adc.66.1_Spec_No.29 Ryley, 1979, Screening for cystic fibrosis in the newborn by meconium analysis, Arch Dis. Child, 54, 92, 10.1136/adc.54.2.92 World Health Organization/International Cystic Fibrosis (Mucoviscidosis) Association Feasibility study of community control programmes for cystic fibrosis. Bull WHO 1990; 68: 709–713. Nazer, 1986, Cystic fibrosis in Jordan – incidence and prevalence, Trans. Roy. Soc. Trop. Med., 4, 1 Forrest, 1981, Screening for cystic fibrosis by a stool trypsin method, Arch Dis. Child, 56, 151, 10.1136/adc.56.2.151 Applegarth, 1979, Dried blood spot screening for cystic fibrosis, Lancet, ii, 1936 King, 1979, Sensitive trypsin assay for dried blood specimens as a screening procedure for early detection of cystic fibrosis, Lancet, ii, 1217, 10.1016/S0140-6736(79)92336-5 Bowling, 1987, Monoclonal antibody-based trypsinogen enzyme immunoassay for screening of neonates for CF, Lancet, i, 826, 10.1016/S0140-6736(87)91607-2 Bowling, 1988, Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbent assay (ELISA) technique, Clin. Chim. Acta, 171, 257, 10.1016/0009-8981(88)90151-9 Soini, 1983, Time-resolved fluorometer for lanthanide chelates — a new generation of nonisotopic immunoassays, Clin. Chem., 29, 65, 10.1093/clinchem/29.1.65 Hemmila, 1984, Europium as a label in time-resolved immunofluorometric assays, Anal Biochem., 137, 335, 10.1016/0003-2697(84)90095-2 Heeley, 1992, The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood, Ann Clin Biochem, 29, 361, 10.1177/000456329202900401 Hammond, 1991, Efficacy of statewide screening for cystic fibrosis by assay of trypsinogen concentrations, N Engl J. Med., 325, 769, 10.1056/NEJM199109123251104 Rock, 1990, Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels, Pediatrics, 85, 1001, 10.1542/peds.85.6.1001 Dhondt, 1994, What does immunoreactive trypsin assays measure?, Screening, 3, 33, 10.1016/0925-6164(94)90033-7 Rusakow, 1993, Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus, Screening, 2, 13, 10.1016/0925-6164(93)90013-9 Bourguignon, 1986, Variations in dried blood spot immunoreactive trypsin in relation to gestational age and during the first week of life, Eur. J. Pediatr, 144, 547, 10.1007/BF00496032 Seltzer, 1991, Screening for cystic fibrosis: feasibility of molecular genetic analysis of dried blood specimens, Biochem. Med. Metab Biol., 46, 105, 10.1016/0885-4505(91)90055-P Gasparini, 1999, Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4,476 newborns for cystic fibrosis, J. Med. Screen, 6, 67, 10.1136/jms.6.2.67 Wilcken, 1995, Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies, J. Pediatr., 127, 965, 10.1016/S0022-3476(95)70040-4 Travert G. Analysis of worldwide experience of neonatal screening for cystic fibrosis by measurement of blood immunoreactive trypsin. In: Travert G (ed.) Mucoviscidose: Depistage Neonatal et Prise en Charge precoce. Caen: CHRU de Caen, 1988; pp. 1–23. Narzi, 2002, Comparison of two different protocols of neonatal screening for cystic fibrosis, Clin Genet, 62, 245, 10.1034/j.1399-0004.2002.620311.x Pollitt, 1997, Neonatal screening for cystic fibrosis in the Trent region: two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step, J. Med. Screen, 4, 23, 10.1177/096914139700400109 Scotet, 2000, Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years’ experience and impact on prenatal diagnosis, Lancet, 356, 789, 10.1016/S0140-6736(00)02652-0 Gregg, 1997, Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods, Pediatrics, 99, 819, 10.1542/peds.99.6.819 Spence, 1993, Neonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity, Biochem. Med. Metab. Biol., 49, 200, 10.1006/bmmb.1993.1022 Ranieri, 1994, Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years’ experience, BMJ, 308, 1469, 10.1136/bmj.308.6942.1469 Bobadilla, 2002, Cystic fibrosis: a worldwide analysis of CFTR mutations – correlation with incidence data and application to screening, Hum. Mutat., 19, 575, 10.1002/humu.10041 Frossard, 1997, Identification of cystic fibrosis mutation in the United Arab Emirates, Hum. Mutat., 11, 412, 10.1002/(SICI)1098-1004(1998)11:5<412::AID-HUMU15>3.0.CO;2-O Massie, 2001, Intron-8 polythymidine sequence in Australasian infants with CF mutations R117H and R117C, Eur. Respir. J., 17, 1195, 10.1183/09031936.01.00057001 Castellani, 1997, CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test, J. Med. Genet., 34, 297, 10.1136/jmg.34.4.297 Ciske, 2001, Genetic counselling and neonatal screening for cystic fibrosis: an assessment of the communication process, Pediatrics, 107, 699, 10.1542/peds.107.4.699 Farrell, 1992, Neonatal screening for cystic fibrosis, Adv. Pediatr., 39, 35 Corbetta, 2002, Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population, J. Med. Screen, 9, 60, 10.1136/jms.9.2.60 Castellani, 1997, Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity, Acta Paediatr., 86, 497, 10.1111/j.1651-2227.1997.tb08920.x Sarles, 1999, Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening in cystic fibrosis, Arch Dis. Child Fetal Neonatal Ed., 80, F118, 10.1136/fn.80.2.F118 Ploier, 1991, Regional mucoviscidosis screening using immunoreactive trypsin in umbilical cord blood, Pädiatr Pädol, 26, 263 Massie, 2000, Sweat testing following newborn screening for cystic fibrosis, Pediatr Pulmonol, 29, 452, 10.1002/(SICI)1099-0496(200006)29:6<452::AID-PPUL7>3.0.CO;2-H